Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10768864 | Biochemical and Biophysical Research Communications | 2005 | 7 Pages |
Abstract
The opening of mitochondrial ATP-sensitive K+ (mitoKATP) channels triggers or mediates the infarct size (IS)-limiting effect of ischemic preconditioning (IP). Because ecto-5â²-nucleotidase related to IP is activated by PKC, we tested whether the opening of mitoKATP channels activates PKC and contributes to either activation of ecto-5â²-nucleotidase or IS-limiting effect. In dogs, IP procedure decreased IS and activated ecto-5â²-nucleotidase, both of which were mimicked by transient exposure to either cromakalim or diazoxide, and these effects were blunted by either GF109203X (a PKC inhibitor) or 5-hydroxydecanoate (a mitoKATP channel blocker), but not by HMR-1098 (a surface sarcolenmal KATP channel blocker). Either cromakalim or diazoxide activated both PKC and ecto-5â²-nucleotidase, which was blunted by either GF109203X or 5-hydroxydecanoate, but not by HMR-1098. We concluded that the opening of mitoKATP channels contributes to either activation of ecto-5â²-nucleotidase or the infarct size-limiting effect via activation of PKC in canine hearts.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Osamu Tsukamoto, Hiroshi Asanuma, Jiyonng Kim, Tetsuo Minamino, Seiji Takashima, Akiko Ogai, Akio Hirata, Masashi Fujita, Yoshiro Shinozaki, Hidezo Mori, Hitonobu Tomoike, Masatsugu Hori, Masafumi Kitakaze,